Novabridge Biosciences earnings were -$24.5M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest NBP earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$6.8M, up 24.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, NBP reported annual earnings of -$22.2M, with -89.3% growth.
Novabridge Biosciences Earnings Reports & History FAQ
What were Novabridge Biosciences's earnings last quarter?
On NBP's earnings call on Invalid Date, Novabridge Biosciences (NASDAQ: NBP) reported Q3 2025 earnings per share (EPS) of -$0.07, up 72.73% year over year. Total NBP earnings for the quarter were -$6.83 million. In the same quarter last year, Novabridge Biosciences's earnings per share (EPS) was -$0.25.
Is Novabridge Biosciences profitable or losing money?
As of the last Novabridge Biosciences earnings report, Novabridge Biosciences is currently losing money. Novabridge Biosciences's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$24.54 million, a 69.04% decrease year over year.
What was NBP's earnings growth in the past year?
As of Novabridge Biosciences's earnings date in Invalid Date, Novabridge Biosciences's earnings has grown year over year. NBP earnings in the past year totalled -$24.54 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.